Newsroom
Category
July 29, 2021
Loss of smell also observed in Argentine sample. Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu DENVER, Colo. (July 29, 2021) — In a sample of over 400 older adults in Argentina who had recovered from COVID-19, more than 60% displayed some degree of cognitive impairment, a researcher from The University of Texas Health Science Center at San […]
July 26, 2021
Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu Ruben Mesa, MD, FACP, executive director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, has been elected to the board of the Association of American Cancer Institutes (AACI). He joins three other new board members to support the organization’s mission of accelerating progress […]
July 26, 2021
Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO – Dentists aren’t known to tell people not to brush, but that’s what happened on the way to a breakthrough. After asking study participants not to brush half their teeth for three weeks, researchers discovered that genetic differences make some people more susceptible to chronic inflammatory diseases that […]
July 22, 2021
NIRVANA clinical study seeks the answer in San Antonio, Seattle and New York Media contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (July 22, 2021) — Researchers at The University of Texas Health Science Center at San Antonio, The University of Washington at Seattle and the Icahn School of Medicine at Mount Sinai in New York have […]
July 6, 2021
Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu A day after baby CJ’s heart stopped, twice, his parents were presented grim options including a future for him hooked to machines or in end-of-life hospice care. Something kept them going, a feeling that they were better prepared than most for months of continuing treatment and life-and-death decisions. CJ was […]
June 30, 2021
Small subsets of high-risk patients produce few or no antibodies, however. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (June 30, 2021) — In a U.S. and Swiss study, nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose, but the fact […]
